(E)-3-(4-TRIFLUOROMETHOXYSTYRYL)-[1.2.4]-TRIAZOLO-[3.4-ALPHA]-PHTHALAZINE
Compound with free spectra: 1 NMR
![(E)-3-(4-TRIFLUOROMETHOXYSTYRYL)-[1.2.4]-TRIAZOLO-[3.4-ALPHA]-PHTHALAZINE](/api/compound/2f8etvBq1a1.png?ph=true&h=300&w=458 "(E)-3-(4-TRIFLUOROMETHOXYSTYRYL)-[1.2.4]-TRIAZOLO-[3.4-ALPHA]-PHTHALAZINE")
| SpectraBase Compound ID | 2f8etvBq1a1 |
|---|---|
| InChI | InChI=1S/C18H11F3N4O/c19-18(20,21)26-14-8-5-12(6-9-14)7-10-16-23-24-17-15-4-2-1-3-13(15)11-22-25(16)17/h1-11H/b10-7+ |
| InChIKey | YNZGJQVYARACOE-JXMROGBWSA-N |
| Mol Weight | 356.31 g/mol |
| Molecular Formula | C18H11F3N4O |
| Exact Mass | 356.088496 g/mol |
| Copyright | Copyright © 2016-2021 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
(E)-3-(4-METHOXYSTYRYL)-[1.2.4]-TRIAZOLO-[3.4-ALPHA]-PHTHALAZINE
(E)-3-(4-ETHOXYSTYRYL)-[1.2.4]-TRIAZOLO-[3.4-ALPHA]-PHTHALAZINE
(E)-3-(4-(2',2',2'-TRIFLUOROETHOXY)-STYRYL)-[1.2.4]-TRIAZOLO-[3.4-ALPHA]-PHTHALAZINE
(E)-3-[4-(3-METHYLBUT-2-ENYLOXY)-STYRYL)-[1.2.4]-TRIAZOLO-[3.4-ALPHA]-PHTHALAZINE
3-(4-((E)-3,7-DIMETHYLOCTA-2,6-DIENYLOXY)-STYRYL)-[1.2.4]-TRIAZOLO-[3.4-ALPHA]-PHTHALAZINE
2-{3-[(E)-2-(3,4-dimethoxyphenyl)ethenyl]-1-[2-(piperidin-1-yl)ethyl]-1H-1,2,4-triazol-5-yl}phenol
5H-[1,2,4]Triazolo[5,1-a]isoindole, 2-[(2,4-dichlorophenoxy)methyl]-
1H-1,2,4-Triazolo[4,3-b][1,2,4]triazolium, 6-(2,4-dimethylphenyl)-2-methyl-3-(methylthio)-, hydroxide, inner salt
3-Phenyl-7,8,9,10,11,11a-hexahydro-6H-cycloocta[e]-s-triazolo[3,4-b][1,3,4]thiadiazine
3-Nitro-N-(4-tolyl)-phthalimide
| Title | Journal or Book | Year |
|---|---|---|
| Design, Synthesis, and Biological Evaluation of New Cinnamic Derivatives as Antituberculosis Agents | Journal of Medicinal Chemistry | 2011 |